Advent Life Sciences LLP 13D and 13G filings for Axonics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-02-11 1:57 pm Sale | 2019-12-31 | 13G | Axonics, Inc. AXNX | Advent Life Sciences LLP | 1,273,859 3.700% | -422,990 (-24.93%) | Filing |